Last viewed: SRNE


Prices are updated after-hours



nasdaq:SRNE Sorrento Therapeutics, Inc.

SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (11.1% 1m) (-96.7% 1y) (0.0% 2d) (0.0% 3d) (-50.0% 7d) (-58.93% volume)
Earnings Calendar: 2023-02-20
Market Cap: $ 8,269,217

http://www.sorrentotherapeutics.com
Sec Filling | Patents | 310 employees


(US) Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

cancer   covid   antibody   t-cell   ceiling  

add to watch list Paper trade email alert is off

Press-releases


Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
Published: 2024-03-27 (Crawled : 13:00) - globenewswire.com
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| | O: -0.66% H: 10.33% C: 7.33%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: -11.11% H: 12.5% C: 0.0%

company
Virpax Pharmaceuticals Reports 2023 Year-End Results
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
VRPX | $3.19 0.95% 3.9K twitter stocktwits trandingview |
| | O: -0.68% H: 3.17% C: 2.65%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: 11.11% H: 0.0% C: -10.0%

virpax pharmaceuticals results
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
Published: 2024-03-15 (Crawled : 13:00) - globenewswire.com
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| | O: 0.72% H: 2.89% C: -2.14%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: -7.14% H: 46.15% C: 38.46%

virpax wholly pharmaceuticals agreement
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
Published: 2024-03-02 (Crawled : 00:20) - globenewswire.com
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| Email alert Add to watchlist

company
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
VRPX | $3.19 0.95% 3.9K twitter stocktwits trandingview |
| | O: -14.39% H: 7.35% C: -0.24%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: 7.14% H: 66.67% C: -11.0%

virpax pharmaceuticals
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
Published: 2024-02-26 (Crawled : 22:00) - globenewswire.com
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| | O: 1.45% H: 15.24% C: 10.0%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: 7.14% H: 66.67% C: -11.0%

virpax wholly pharmaceuticals agreement
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 9.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.82% C: -0.74%
NVS | News | $97.755 0.49% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: -63.33% H: 263.64% C: 127.27%
GILD | $66.99 -0.06% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.265 -4.8% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 11.52% C: 4.94%

drug report t-cell global therapy market
Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| | O: 3.82% H: 5.76% C: 1.04%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: -2.03% H: 3.42% C: -1.08%

company
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
VRPX | $3.19 0.95% 3.9K twitter stocktwits trandingview |
| | O: 6.92% H: 0.0% C: -7.88%
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 14.29% C: 3.05%

nasdaq virpax pharmaceuticals
UPDATE -- Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure
Published: 2023-10-27 (Crawled : 20:00) - globenewswire.com
SRNE | $0.015 56K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SCLX | $0.9066 -7.18% 540K twitter stocktwits trandingview |
| Email alert Add to watchlist

company update order
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56% 44%

Top 10 Gainers
CZOO | $10.52 110.82% 10M twitter stocktwits trandingview |

CSSE 4 | $0.3181 108.86% 170M twitter stocktwits trandingview |
Consumer Services

BOF | $1.88 60.68% 98M twitter stocktwits trandingview |

AMST | $3.1 55.0% 66M twitter stocktwits trandingview |
Technology Services

LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.03 41.99% 15M twitter stocktwits trandingview |
Technology Services

MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information

RILY | $28.605 31.7% 9.9M twitter stocktwits trandingview |
Finance

RBBN 4 | $3.305 28.6% 1.9M twitter stocktwits trandingview |
Electronic Technology

RCAT | $1.53 27.5% 2.9M twitter stocktwits trandingview |
Information


Last 48 Hours Insiders Buying
NWFL | News | $24.0 -0.46% 4.6K twitter stocktwits trandingview |
Finance
| 17:00
MNSB P 310 | $15.91 -2.75% 18K twitter stocktwits trandingview |
Finance
| 15:30
TPL P 3 | $585.605 -0.38% 11K twitter stocktwits trandingview |
Miscellaneous
| 15:01
ISBA P 966 | $18.0001 3.1K twitter stocktwits trandingview |
Finance and Insurance
| 15:01
MEGI | $11.98 74K twitter stocktwits trandingview |
| 00:30
CTRN P 29000 | $21.855 -1.69% 26K twitter stocktwits trandingview |
Retail Trade
| 22:00
CONN | $3.735 0.95% 23K twitter stocktwits trandingview |
Retail Trade
| 21:30
TGEN P 6000 | $0.685 6.6K twitter stocktwits trandingview |
Utilities
| 18:30
CMTV P 700 | $16.59 1K twitter stocktwits trandingview |
Finance and Insurance
| 18:30
FNB | $13.625 -0.04% 700K twitter stocktwits trandingview |
Finance
| 17:30
RMCF | $3.54 7K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar